Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
azithromycin lomitapide

increases exposure

Unknown Theoretical
azithromycin paclitaxel

increases exposure

Unknown Theoretical
azithromycin rimegepant

increases exposure

Unknown Theoretical
azithromycin taxanes

increases exposure

Unknown Theoretical
azithromycin vincaalkaloids

increases exposure

Unknown Theoretical
baclofen levodopa

increases risk of adverseeffects

Unknown Anecdotal
balsalazide digoxin

decreases concentration

Unknown Theoretical
belzutifan combinedhormonalcontraceptives

decreases efficacy

Unknown Theoretical
bempedoicacid pravastatin

increases exposure

Unknown Study
bempedoicacid simvastatin

increases exposure

Unknown Study
bempedoicacid statins

increases exposure

Unknown Study
benperidol levodopa

decreases effects

Unknown Study
berotralstat desogestrel-containingcontraceptives

decreases efficacy

Unknown Theoretical
berotralstat ergotamine

increases exposure

Unknown Study
berotralstat pimozide

increases exposure

Unknown Study
berotralstat tacrolimus

increases exposure

Unknown Study
beta 2agonists ipratropium

increases risk of glaucoma

Unknown Anecdotal
betablockers,non-selective relugolix

increases exposure

Unknown Theoretical
betablockers,selective adrenalineepinephrine

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective adrenalineepinephrine

increases risk of hypertensionandbradycardia

Unknown Study
betablockers,selective ergometrine

increases risk of peripheralvasoconstriction

Unknown Study
betablockers,selective ergotamine

increases risk of peripheralvasoconstriction

Unknown Study
betablockers,selective lanreotide

increases risk of bradycardia

Unknown Theoretical
betablockers,selective noradrenalinenorepinephrine

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective noradrenalinenorepinephrine

increases risk of hypertensionandbradycardia

Unknown Study
betablockers,selective sympathomimetics,vasoconstrictor

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective sympathomimetics,vasoconstrictor

increases risk of hypertensionandbradycardia

Unknown Study
bezafibrate ciclosporin

increases risk of nephrotoxicity

Unknown Theoretical
bicalutamide lomitapide

increases exposure

Unknown Theoretical
bictegravir metformin

increases exposure

Unknown Study
bictegravir methadone

increases exposure

Unknown Theoretical
bictegravir opioids

increases exposure

Unknown Theoretical
bimekizumab coumarins

affects exposure

Unknown Theoretical
bimekizumab warfarin

affects exposure

Unknown Theoretical
bismuthsubsalicylate drugswithanticoagulanteffects

increases risk of bleedingevents

Unknown Theoretical
bismuthsubsalicylate seetablep

increases risk of bleedingevents

Unknown Theoretical
bisphosphonates deferasirox

increases risk of gastrointestinalbleeding

Unknown Theoretical
bisphosphonates ironchelators

increases risk of gastrointestinalbleeding

Unknown Theoretical
bosentan acalabrutinib

decreases exposure

Unknown Study
bosentan anti-androgens

decreases efficacy

Unknown Study
bosentan antiarrhythmics

decreases exposure

Unknown Theoretical
bosentan atorvastatin

decreases exposure

Unknown Study
bosentan avacopan

decreases exposure

Unknown Theoretical
bosentan avapritinib

decreases exposure

Unknown Study
bosentan axitinib

decreases exposure

Unknown Study
bosentan bedaquiline

decreases exposure

Unknown Study
bosentan bosutinib

decreases exposure

Unknown Study
bosentan brigatinib

decreases exposure

Unknown Study
bosentan cabazitaxel

decreases exposure

Unknown Theoretical
bosentan cabozantinib

decreases exposure

Unknown Study
Prev 1 ... 53 54 55 56 57 ... 126 Next
6278 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.